Company profilePharmaceutical#810 of 1,318 in Pakistan✓ No DRAP alerts

WISDOM

Pharmaceutical company · 9 brands · 11 molecules

Ranked #10 of 22 companies in Corticosteroid, Plain

9 registered products 12 pharmaceutical brands 11 distinct molecules 0 DRAP alerts

Company overview

9
registered products
12
pharmaceutical brands
11
distinct molecules
7
therapeutic classes
0
DRAP alerts

WISDOM is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 9 product registrations across 11 distinct molecules. Its portfolio is concentrated in Corticosteroid, Plain and Antifungal For Dermatological. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Clobetasol2 brands
Miconazole1 brand
Itraconazole ...... 100 Mg1 brand

Therapeutic classes

Corticosteroid, Plain · 2Antifungal For Dermatological · 2Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Anti-Acne Preparations · 1Corticosteroid Combinations, Topical · 1Antimycotics Systemic Use · 1Ectoparasiticides; Scabicides · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 590.42 – Rs 590.42
DVAGO1 products · Rs 464.56 – Rs 464.56
Median across source: Rs 590.42

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

VALOR PHARMACEUTICALS10 shared molecules
BIO LABS (PVT) LTD.8 shared molecules
SHROOQ PHARMACEUTICALS7 shared molecules
DERMA TECHNO PAKISTAN7 shared molecules
PEARL PHARMACEUTICALS6 shared molecules

Get the full profile for WISDOM

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.